Chesapeake Utilities (CPK) Q1 2025 Earnings Call May 08, 2025 08:00 AM ET Speaker0 Welcome to Chesapeake Utilities Corporation's First Quarter twenty twenty five Earnings Conference Call. I would now like to turn the call over to Lucia Dempsey, Head of Investor Relations. Speaker1 Thank you, and good morning, everyone. Today's presentation can be accessed on our website under the Investors page and Events and Presentations subsection. After our prepared remarks, we will open up the call for questions. On Sl ...

2025 Q1 Earnings May 8, 2025 Forward Looking Statement & Disclosures Except for specific historical information, many of the matters discussed in this presentation may express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These statements may discuss goals, intentions and expectations as to future trends, plans, events, results of operations or financial condition, or state other information relating to ...

New York, NY, May 08, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the first quarter ended March 31, 2025. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: "We had a solid start to the year as the quarter marked continued progress on our transformation and our Bonds and Beyond strategy, with first quarter sales coming in ahead of our expectations. As we look ahead, we believe in our ability to navigate the dyna ...

Second Quarter Fiscal 2025 | Earnings Call May 8, 2025 NYSE: BV Introductory Information 2Q FY2025 Earnings Presentation | 2 Introductory Information (con't.) Executive Summary Dale Asplund | President & Chief Executive Officer 2Q FY2025 Earnings Presentation | 4 Key Highlights & Strategic Priorities Raising FY25 Adjusted EBITDA, Margin & Free Cash Flow Guidance Business Update 2Q FY2025 Earnings Presentation | 3 Delivered record EBITDA and margin with margin expansion of +150bps Resilient business model po ...

Company reaffirms full-year adjusted EBITDA 2025 outlook and five-year sales and margin targets Company initiates full-year 2025 free cash flow guidance of $14-$16 million CHARLOTTE, N.C., May 07, 2025 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR) (“NN” or the “Company”), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, today reported results for the first quarter ended March 31, 2025. First Quarter Highlights Net sales of $105.7 million, decre ...

Financial Data and Key Metrics Changes - IFF generated approximately $2.8 billion in sales for Q1 2025, representing a 3% comparable currency neutral growth [10] - Adjusted operating EBITDA totaled $578 million for the quarter, a strong 9% increase on a comparable currency neutral basis [10] - Comparable currency neutral adjusted operating EBITDA margin increased more than 120 basis points to 20.3% [10] Business Line Data and Key Metrics Changes - Pharma Solutions delivered $266 million in sales, an 8% year-over-year increase on a comparable currency neutral basis [11] - Taste segment sales were $627 million, a 7% year-over-year increase on a comparable currency neutral basis [13] - Food Ingredients had sales of $796 million, a 4% comparable currency neutral decrease from the prior year [13] - Health and Biosciences segment delivered a 5% increase in comparable currency neutral sales [14] - Scent achieved net sales of $614 million, up 4% year-over-year on a comparable currency neutral basis [14] Market Data and Key Metrics Changes - The company noted that broader macroeconomic dynamics remain challenging, but IFF's portfolio is grounded in resilient essential end markets [20] - The company expects approximately 2% adverse impact on revenue from foreign exchange, down from 4% previously [22] Company Strategy and Development Direction - IFF is focused on strengthening its business through consistent reinvestment in core growth drivers: R&D, commercial, digital, and capacity [20] - The company is maintaining its full-year guidance ranges despite macroeconomic uncertainties [21] - IFF completed the divestiture of Pharma Solutions, which strengthens its capital structure and helps achieve a net debt to credit adjusted EBITDA ratio of below three times [7][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the order book remaining consistent with guidance despite macroeconomic uncertainties [28] - The company is actively working with customers to mitigate impacts of tariff actions and remains disciplined in response to macroeconomic uncertainty [9] - Management acknowledged concerns about potential recessionary pressures but emphasized the resilience of 80% of its portfolio in essential products [29] Other Important Information - Cash flow from operations totaled $127 million year-to-date, with CapEx at $179 million, approximately 6% of sales [15] - Gross debt was approximately $9.3 billion, a decrease of more than $1 billion compared to the year-ago period [17] Q&A Session All Questions and Answers Question: Can you talk us through which areas of the portfolio could potentially be at risk and which parts could be more resilient in a recessionary scenario? - Management indicated that 80% of the portfolio is in essential products, which are resilient, while discretionary areas like fine fragrances may be at risk [29] Question: Can you disclose what you think the gross impact today is on your costs from tariffs? - Management noted a gross exposure of over $100 million for 2025 related to tariffs, primarily from China, but emphasized successful supply chain optimization efforts [35] Question: What were the year-ago comps for flavors and food ingredients? - Management reported that Taste grew 11% last year in Q1, while Food Ingredients declined 4% last year [40] Question: Can you elaborate on the strategic rationale for the joint venture with Chimera? - The joint venture aims to scale enzymatic biomaterials and is expected to start operations by the end of 2027, targeting high-value biodegradable polymers [44][46] Question: What drove volumes lower in protein solutions? - Management indicated that volumes were down due to weaker performance in lower-value areas and production issues in higher-value areas, which are being resolved [55] Question: How do you see the inventory cycle affecting IFF? - Management expressed that they do not believe inventory levels are elevated enough to cause a significant downtick, given the recent destocking period [88]

Caesarstone (CSTE) Q1 2025 Earnings Call May 07, 2025 08:30 AM ET Company Participants Brad Cray - Vice PresidentYosef Shiran - Chief Executive OfficerNahum Trost - Chief Financial Officer Conference Call Participants Reuben Garner - Equity Research Analyst Operator Greetings, and welcome to the Caesarstone First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. To ask a ques ...

Delivered 25% YoY revenue growth driven by PAC business turnaround Achieved 8th straight quarter of double-digit YoY ASP growth, strong gross margins of 36.4%, 4th consecutive quarter of positive Adjusted EBITDA and positive net income for the quarter Signed second largest PAC contract in Arq’s history, evidencing sustainability and value of foundational business Updating timing for first commercial GAC production at Red River to end of Q2 or early Q3 2025 Appointed Jay Voncannon as Chief Financial Officer ...

BONDUELLE Head office: "La Woestyne" - 59173 Renescure - FranceBonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 eurosRegistered under number : 447 250 044 ( Dunkerque Commercial and Companies Register) Quarter 3 FY 2024-2025 Sales (January 1 - March 31, 2025) The Bonduelle Group confirms its annuals objectives and posts stability in its business activity for Quarter 3 The Bonduelle Group sales for Quarter 3 (January 1 - March 31, 2025) of FY 2024-2025, were stable com ...

Sealed Air (SEE) Q1 2025 Earnings Call May 06, 2025 10:00 AM ET Company Participants Mark Stone - VP - Investor RelationsDustin Semach - President & CEOVeronika Johnson - Interim CFOGeorge Staphos - Managing DirectorPhilip Ng - Managing DirectorMichael Roxland - MD - Equity ResearchJosh Spector - Executive DirectorStefan Diaz - Vice President, Equity Research Conference Call Participants Ghansham Panjabi - Senior Research AnalystMatthew Roberts - Equity Research AnalystJeff Zekauskas - AnalystGabe Hajde - A ...